{
    "clinical_study": {
        "@rank": "142952", 
        "brief_summary": {
            "textblock": "Purpose: This study is a Randomized, Double Blind, Multi-center, Active Drug Controlled,\n      Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox\u00ae in\n      Treatment of Post Stroke Upper Limb(wrist, finger, elbow, thumb)Spasticity."
        }, 
        "brief_title": "A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox\u00ae in Treatment of Post Stroke Upper Limb Spasticity", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Post Stroke Upper Limb Spasticity", 
        "condition_browse": {
            "mesh_term": [
                "Muscle Spasticity", 
                "Stroke"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Male or female adult patients\n\n          2. \u2265 6 weeks since the last stroke\n\n        Exclusion Criteria:\n\n        1.Patients with diagnosed neuromuscular disorders such as Lamber-Eaton syndrome,\n        myasthenia gravis, or amyotrophic lateral sclerosis."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "September 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01945684", 
            "org_study_id": "DW_DWP450002"
        }, 
        "intervention": {
            "description": "Maximum dose 360 U", 
            "intervention_name": "Botulinum toxin type A", 
            "intervention_type": "Drug", 
            "other_name": [
                "Assigned Interventions", 
                "Experimental: DWP450", 
                "Botulinum toxin type A Drug: Botulinum toxin type A", 
                "Active Comparator: Botox\u00ae", 
                "Botulinum Toxin type A Drug: Botulinum Toxin type A (Botox\u00ae)"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Botulinum Toxins, Type A", 
                "Botulinum Toxins"
            ]
        }, 
        "lastchanged_date": "September 17, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "156-707"
                }, 
                "name": "SMG-SNU Boramae Medical Center, 41, Borame-Gill, Dong Gjak-Gu"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "overall_contact": {
            "last_name": "KA YOUNG JUNG", 
            "phone": "02-550-8276"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Ministry of Food and Drug Safety", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The change in MAS (Modified Ashworth Scale) grade from baseline at week 4 for wrist flexor muscle tone", 
            "measure": "The change in MAS(Modified Ashworth Scale)grade for Wrist flexor", 
            "safety_issue": "No", 
            "time_frame": "at 4 week"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01945684"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Daewoong Pharmaceutical Co. LTD.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Daewoong Pharmaceutical Co. LTD.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "N/A", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}